Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Artificial Intelligence-Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Chronic Lymphocytic Leukemia

April Chiu, Jansen N Seheult, Min Shi, Dragan Jevremovic, Matthew J Weybright, Michael M Timm, Gregory E Otteson, Horatiu Olteanu, Pedro Horna

Blood (2024) 144 (Supplement 1): 1858.

https://doi.org/10.1182/blood-2024-199901

Published: 2024

Journal Articles

Development of a Three-Gene-Based Proliferation Score (3GPS) to Predict Proliferation Index in Newly Diagnosed Multiple Myeloma

Arwa Bohra, Surendra Dasari, Wilson I. Gonsalves, Prashant Kapoor, Saurabh Zanwar, Moritz Binder, Angela Dispenzieri, Michael M Timm, Dragan Jevremovic, S. Vincent Rajkumar, Shaji Kumar

Blood (2024) 144 (Supplement 1): 1945.

https://doi.org/10.1182/blood-2024-211902

Published: 2024

Journal Articles

Artificial Intelligence-Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual B Lymphoblastic Leukemia

Jansen N Seheult, Matthew J Weybright, Min Shi, Dragan Jevremovic, April Chiu, Michael M Timm, Gregory E Otteson, Horatiu Olteanu, Pedro Horna

Blood (2024) 144 (Supplement 1): 4226.

https://doi.org/10.1182/blood-2024-199894

Published: 2024

Journal Articles

Machine Learning Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Acute Myeloid Leukemia

Jansen N Seheult, Min Shi, Horatiu Olteanu, Gregory E Otteson, Michael M Timm, Matthew J Weybright, Pedro Horna

Blood (2023) 142 (Supplement 1): 4339.

https://doi.org/10.1182/blood-2023-190275

Published: 2023

Journal Articles

Cell-Type and Allele Specific Distribution of Multiple TET2 Mutations in Two Patients with Chronic Myelomonocytic Leukemia (CMML)

Terra Lasho, Christy Finke, Michael M. Timm, Robert Durruthy-Durruthy, Marc Arribas-Layton, Mrinal M. Patnaik, Ayalew Tefferi, Naseema Gangat, Abhishek A. Mangaonkar, Moritz Binder, Alexandre Gaspar Maia, Wazim Mohammed Ismail, Matthew T Howard, Nicholas Chia

Blood (2021) 138 (Supplement 1): 1470.

https://doi.org/10.1182/blood-2021-153802

Published: 2021

Journal Articles

Predictors of Survival and Time to Progression to Myeloid Neoplasm in Patients with Clonal Cytopenias

Ahmad Nanaa, Rama Nana, Zhuoer Xie, MD, Dragan Jevremovic, MD PhD, Phuong L. Nguyen, MD, Cynthia Hengel, Susan M. Geyer, PhD, Rong He, MD, David S. Viswanatha, MD, Michael M. Timm, Mohamed E Salama, MD, Min Shi, MDPhD, Patricia Greipp, DO, Hassan B. Alkhateeb, MD, William J Hogan, MB, BCh, Mark Litzow, MD, Mrinal M. Patnaik, MDMBBS, Mithun Vinod Shah, MD PhD, Aref Al-Kali, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-142181

Published: 2020

Journal Articles

Correlation of Flow Cytometric Aberrations with Cytogenetic, Molecular Genetic, and Morphology in Patients with Unexplained Cytopenias

Haya Azouz, Jessica Ternus, Phuong L. Nguyen, MD, Dragan Jevremovic, MD PhD, Mrinal M Patnaik, MDMBBS, Michael M. Timm, Min Shi, MD PhD, Rong He, MD, David S. Viswanatha, Mithun Vinod Shah, MD PhD, Hassan B. Alkhateeb, MD, Naseema Gangat, MBBS, Kebede H. Begna, MD, William J Hogan, MB, BCh, Mark Litzow, MD, Cindy Hengel, Aref Al-Kali, MD

Blood (2019) 134 (Supplement_1): 5406.

https://doi.org/10.1182/blood-2019-125114

Published: 2019

Journal Articles

The Prognostic Significance of Polyclonal Bone Marrow Plasma Cells in Patients with Actively Relapsing Multiple Myeloma

Blood (2016) 128 (22): 1194.

https://doi.org/10.1182/blood.V128.22.1194.1194

Published: 2016

Journal Articles

Measurement of the Proliferation of Clonal Plasma Cells By Multiparametric Flow Cytometry Is a Clinically Useful Tool in Multiple Myeloma

Samith T. Kochuparambil, MBBS, William G. Morice, MD PhD, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD, Michael M Timm, Martha Q Lacy, MD, Morie A Gertz, MD MACP, Shaji Kumar, MD

Blood (2014) 124 (21): 2053.

https://doi.org/10.1182/blood.V124.21.2053.2053

Published: 2014

Journal Articles

Increased Circulating Plasma Cells On Multiparametric Flow Cytometry As An Independent Prognostic Biomarker In Newly Diagnosed Multiple Myeloma: Implications For Redefining High-Risk Myeloma

Wilson I Gonsalves, MD, Vinay Gupta, MBBS, S. Vincent Rajkumar, MD, William G Morice, MD, PhD, Michael M Timm, Preet Paul Singh, MD, Angela Dispenzieri, MD, Francis K Buadi, MD, Martha Q Lacy, MD, Prashant Kapoor, MD, Morie A Gertz, MD, MACP, Shaji K Kumar, MD

Blood (2013) 122 (21): 1842.

https://doi.org/10.1182/blood.V122.21.1842.1842

Published: 2013

Journal Articles

Prognostic Value Of Quantifying Circulating Plasma Cells By Multiparametric Flow Cytometry In Patients With Relapsed Multiple Myeloma

Wilson I Gonsalves, MD, Vinay Gupta, MBBS, S. Vincent Rajkumar, MD, William G Morice, MD, PhD, Michael M Timm, Preet Paul Singh, MD, Morie A Gertz, MD, Francis K Buadi, MD, Martha Q Lacy, MD, Prashant Kapoor, MD, Angela Dispenzieri, MD, Shaji K Kumar, MD

Blood (2013) 122 (21): 754.

https://doi.org/10.1182/blood.V122.21.754.754

Published: 2013

Journal Articles

Changes in Bone Marrow Plasma Cell Surface Markers Following CD138-Magnetic Bead Based Positive Selection.

Teresa K. Kimlinger, S. Vincent Rajkumar, MD, Michael P. Kline, Ph.D, Jessica L. Haug, Michael M. Timm, Thomas E. Witzig, MD, Shaji Kumar, MD

Blood (2006) 108 (11): 3516.

https://doi.org/10.1182/blood.V108.11.3516.3516

Published: 2006

Journal Articles

Epigallocatechin-3-Gallate (EGCG), a Polyphenol Extracted from Green Tea, Has Significant In Vitro Activity Against Myeloma Cells.

Shaji Kumar, MD, Michael M. Timm, Jessica L. Haug, Teresa K. Kimlinger, Linda Wellik, Michael P. Kline, Ph.D, S. Vincent Rajkumar, MD

Blood (2006) 108 (11): 3465.

https://doi.org/10.1182/blood.V108.11.3465.3465

Published: 2006

Journal Articles

Apoptosis Rates in Myeloma Cells Can Be Significantly Affected by CD138 Sorting and by the Specific Method Used To Detect Apoptotic Cells.

Teresa K. Kimlinger, BA, S. Vincent Rajkumar, MD, Michael Kline, Ph.D, Michael M. Timm, Jessica L. Haug, Thomas E. Witzig, M.D, Shaji Kumar, M.D

Blood (2006) 108 (11): 3442.

https://doi.org/10.1182/blood.V108.11.3442.3442

Published: 2006

Journal Articles

Phenotypic Characterization of the CD45+ and CD45− Plasma Cell Compartments in Monoclonal Gammopathies.

Teresa K. Kimlimger, Michael M. Timm, S. Vincent Rajkumar, MD, Jessica L. Haug, Michael P. Kline, Ph.D, Thomas E. Witzig, MD, Shaji Kumar, MD

Blood (2006) 108 (11): 3505.

https://doi.org/10.1182/blood.V108.11.3505.3505

Published: 2006

Journal Articles

Induction of Vascular Endothelial Growth Factor (VEGF) and Interleukin 6 (IL-6) in Stromal Cells by Plasma Cells from Different Stages of Myeloma.

Jessica L. Haug, S. Vincent Rajkumar, MD, John A. Lust, MD, Thomas E. Witzig, MD, Teresa K. Kimlinger, Michael M. Timm, Michael P. Kline, Ph.D, Linda Wellik, Shaji Kumar, MD

Blood (2006) 108 (11): 5065.

https://doi.org/10.1182/blood.V108.11.5065.5065

Published: 2006

Journal Articles

Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress

Crescent R. Isham, Jennifer D. Tibodeau, Wendy Jin, Ruifang Xu, Michael M. Timm, Keith C. Bible

Blood (2006) 109 (6): 2579–2588.

https://doi.org/10.1182/blood-2006-07-027326

Published: 2006

Includes: Supplemental data

Journal Articles

A Local Versus Centralized Processing Comparison of Plasma Cell Isolation, Viability, and RNA Integrity.

Gregory J. Ahmann, Kimberly J. Henderson, Tammy L. Price-Troska, Michael M. Timm, Rempel Rachel, Roberta W. DeGoey, Christy M. Finke, Angela Dispenzieri, Philip R. Greipp, Alicia Sable-Hunt, Leif Bergsagel, Rafael Fonseca

Blood (2005) 106 (11): 3413.

https://doi.org/10.1182/blood.V106.11.3413.3413

Published: 2005

Journal Articles

The Role of CXCR4 Inhibitors as Novel Antiangiogenesis Agents in Cancer Therapy.

Irene M. Ghobrial, MD, Michael M. Timm, BS, Karen E. Hedin, PhD, Thomas E. Witzig, MD

Blood (2004) 104 (11): 1296.

https://doi.org/10.1182/blood.V104.11.1296.1296

Published: 2004

Journal Articles

Oncolytic Measles Virus Selectively Targets CD46 Overexpression on Myeloma Cells.

Kah-Whye Peng, PhD, Michael M. Timm, David Dingli, MD, PhD, Angela Dispenzieri, MD, Morie Gertz, MD, Thomas E. Witzig, MD, Philip R. Greipp, MD, Stephen J. Russell, MD, PhD

Blood (2004) 104 (11): 2392.

https://doi.org/10.1182/blood.V104.11.2392.2392

Published: 2004

NARROW

Artificial Intelligence-Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Chronic Lymphocytic Leukemia

Development of a Three-Gene-Based Proliferation Score (3GPS) to Predict Proliferation Index in Newly Diagnosed Multiple Myeloma

Artificial Intelligence-Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual B Lymphoblastic Leukemia

Machine Learning Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Acute Myeloid Leukemia

Cell-Type and Allele Specific Distribution of Multiple TET2 Mutations in Two Patients with Chronic Myelomonocytic Leukemia (CMML)

Predictors of Survival and Time to Progression to Myeloid Neoplasm in Patients with Clonal Cytopenias

Correlation of Flow Cytometric Aberrations with Cytogenetic, Molecular Genetic, and Morphology in Patients with Unexplained Cytopenias

The Prognostic Significance of Polyclonal Bone Marrow Plasma Cells in Patients with Actively Relapsing Multiple Myeloma

Measurement of the Proliferation of Clonal Plasma Cells By Multiparametric Flow Cytometry Is a Clinically Useful Tool in Multiple Myeloma

Increased Circulating Plasma Cells On Multiparametric Flow Cytometry As An Independent Prognostic Biomarker In Newly Diagnosed Multiple Myeloma: Implications For Redefining High-Risk Myeloma

Prognostic Value Of Quantifying Circulating Plasma Cells By Multiparametric Flow Cytometry In Patients With Relapsed Multiple Myeloma

Changes in Bone Marrow Plasma Cell Surface Markers Following CD138-Magnetic Bead Based Positive Selection.

Epigallocatechin-3-Gallate (EGCG), a Polyphenol Extracted from Green Tea, Has Significant In Vitro Activity Against Myeloma Cells.

Apoptosis Rates in Myeloma Cells Can Be Significantly Affected by CD138 Sorting and by the Specific Method Used To Detect Apoptotic Cells.

Phenotypic Characterization of the CD45+ and CD45− Plasma Cell Compartments in Monoclonal Gammopathies.

Induction of Vascular Endothelial Growth Factor (VEGF) and Interleukin 6 (IL-6) in Stromal Cells by Plasma Cells from Different Stages of Myeloma.

Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress

A Local Versus Centralized Processing Comparison of Plasma Cell Isolation, Viability, and RNA Integrity.

The Role of CXCR4 Inhibitors as Novel Antiangiogenesis Agents in Cancer Therapy.

Oncolytic Measles Virus Selectively Targets CD46 Overexpression on Myeloma Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only